NOS3 and hyperlipidemia: In previous study, pitavastatin had been shown to induce EPC proliferation via increased the endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) expression in high-risk patients including those with hyperlipidemia and T2DM13.